AIM: To establish stable tetracycline-inducible pancreatic cancer cell lines. METHODS: Suit-2, MiaPaca-2, and Panc-1 cells were transfected with a second generation reverse tetracycline-controlled transactivator protein (rtTA2S-M2), under the control of either a cytomegalovirus (CMV) or a chicken β-actin promoter, and the resulting clones were characterised. RESULTS: Use of the chicken (β-actin) promoter proved superior for both the production and maintenance of doxycycline-inducible cell lines. The system proved versatile, enabling transient inducible expression of a variety of genes, including GST-P, CYP2E1, S100A6, and the actin capping protein, CapG. To determine the physiological utility of this system in pancreatic cancer cells, stable inducible CapG expressors were established. Overexpressed CapG was localised to the cytoplasm and the nuclear membrane, but was not observed in the nucleus. High CapG levels were associated with enhanced motility, but not with changes to the cell cycle, or cellular proliferation. In CapG-overexpressing cells, the levels and phosphorylation status of other actin-moduating proteins (Cofilin and Ezrin/Radixin) were not altered. However, preliminary analyses suggest that the levels of other cellular proteins, such as ornithine aminotransferase and enolase, are altered upon CapG induction. CONCLUSION: We have generated pancreatic-cancer derived cell lines in which gene expression is fully controllable.
AIM: To establish stable tetracycline-inducible pancreatic cancer cell lines. METHODS: Suit-2, MiaPaca-2, and Panc-1 cells were transfected with a second generation reverse tetracycline-controlled transactivator protein (rtTA2S-M2), under the control of either a cytomegalovirus (CMV) or a chicken β-actin promoter, and the resulting clones were characterised. RESULTS: Use of the chicken (β-actin) promoter proved superior for both the production and maintenance of doxycycline-inducible cell lines. The system proved versatile, enabling transient inducible expression of a variety of genes, including GST-P, CYP2E1, S100A6, and the actin capping protein, CapG. To determine the physiological utility of this system in pancreatic cancer cells, stable inducible CapG expressors were established. Overexpressed CapG was localised to the cytoplasm and the nuclear membrane, but was not observed in the nucleus. High CapG levels were associated with enhanced motility, but not with changes to the cell cycle, or cellular proliferation. In CapG-overexpressing cells, the levels and phosphorylation status of other actin-moduating proteins (Cofilin and Ezrin/Radixin) were not altered. However, preliminary analyses suggest that the levels of other cellular proteins, such as ornithine aminotransferase and enolase, are altered upon CapG induction. CONCLUSION: We have generated pancreatic-cancer derived cell lines in which gene expression is fully controllable.
Entities:
Keywords:
CapG; MiaPaCa-2; Panc-1; Pancreatic cancer cells; Suit-2; Tetracycline-inducible
Authors: Chris E P Goldring; Neil R Kitteringham; Rosalind Jenkins; Cerys A Lovatt; Laura E Randle; Azman Abdullah; Andrew Owen; Xiaoping Liu; Philip J Butler; Dominic P Williams; Peter Metcalfe; Christian Berens; Wolfgang Hillen; Brian Foster; Alec Simpson; Lesley McLellan; B Kevin Park Journal: Am J Physiol Cell Physiol Date: 2005-08-31 Impact factor: 4.249
Authors: Dale Vimalachandran; William Greenhalf; Christopher Thompson; Jutta Lüttges; Wendy Prime; Fiona Campbell; Andrew Dodson; Richard Watson; Tatjana Crnogorac-Jurcevic; Nicholas Lemoine; John Neoptolemos; Eithne Costello Journal: Cancer Res Date: 2005-04-15 Impact factor: 12.701
Authors: C C Thompson; F J Ashcroft; S Patel; G Saraga; D Vimalachandran; W Prime; F Campbell; A Dodson; R E Jenkins; N R Lemoine; T Crnogorac-Jurcevic; H L Yin; E Costello Journal: Gut Date: 2006-07-17 Impact factor: 23.059
Authors: Wafa Abu-Alainin; Thompson Gana; Triantafillos Liloglou; Adedamola Olayanju; Lawrence N Barrera; Robert Ferguson; Fiona Campbell; Timothy Andrews; Christopher Goldring; Neil Kitteringham; Brian K Park; Taoufik Nedjadi; Michael C Schmid; Joseph R Slupsky; William Greenhalf; John P Neoptolemos; Eithne Costello Journal: J Pathol Date: 2015-11-30 Impact factor: 7.996